BridgeBio and Community Partners Launch Nationwide ATTR-CM Education Effort Ahead of World Amyloidosis Day
BridgeBio Pharma launched a nationwide education effort with community partners to raise awareness of ATTR-CM, an underrecognized cause of heart failure. The campaign anchors on an October 6 YouTube premiere moderated by Sway Calloway featuring ATTR-CM advocate Howard "H" White, with programming continuing through World Amyloidosis Day on October 26 across 40 viewing locations nationwide. Partners include the Association of Black Cardiologists, National Minority Quality Forum, 100 Black Men of the Bay Area, and the National Medical Association; roughly 1 in 25 Black Americans carries the V142I (V122I) genetic variant associated with ATTR-CM.
Key figures
- Viewing locations
- 40
- Variant prevalence
- 1 in 25 Black Americans carries the V142I (V122I) variant associated with ATTR-CM
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.